首页> Therapeutic innovation & regulatory science> Incentivizing Quality in the Manufacture of Pharmaceuticals: Industry Views on Quality Metrics and Ratings.

Incentivizing Quality in the Manufacture of Pharmaceuticals: Industry Views on Quality Metrics and Ratings.

导出 LinkOut

翻译打印收藏纠错

第一作者： Cesar,Medina

第一单位： 1 International Center for Regulatory Science, School of Pharmacy, University of Southern California, Los Angeles, CA, USA.;2 Global Regulatory Affairs CMC, Amgen Inc, Thousand Oaks, CA, USA.

作者： Cesar,Medina ^[1] ; Frances J,Richmond ^[2]

作者单位： 1 International Center for Regulatory Science, School of Pharmacy, University of Southern California, Los Angeles, CA, USA.;2 Global Regulatory Affairs CMC, Amgen Inc, Thousand Oaks, CA, USA. ^[1] 1 International Center for Regulatory Science, School of Pharmacy, University of Southern California, Los Angeles, CA, USA. ^[2]

关键词 GMP drug shortages incentives metrics scorecards

DOI 10.1177/2168479015589821

PMID 30227034

发布时间 2020-01-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Therapeutic innovation & regulatory science

2015年49卷5期

730-738页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Therapeutic innovation & regulatory science

2015年49卷5期

730-738页

检索历史清除

Incentivizing Quality in the Manufacture of Pharmaceuticals: Industry Views on Quality Metrics and Ratings.

Therapeutic innovation & regulatory science

相似文献

Therapeutic innovation & regulatory science

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Incentivizing Quality in the Manufacture of Pharmaceuticals: Industry Views on Quality Metrics and Ratings.

Therapeutic innovation & regulatory science

相似文献

Therapeutic innovation & regulatory science

相关期刊

检索历史清除